Akses terbuka Jurnal SINTA 1
Mortality Comparison of Using Anti Interleukin-6 Therapy and Using Standard Treatment in Severe Covid-19
Folia Medica Indonesiana · Vol. 57 No. 2 (2021) · hlm. 158–158
- ISSN
- 2355-8393, 2599-056X
- Terbit
- 2021-06-01
- Penerbit
- Airlangga University
- Bahasa
- en
Abstrak
Severe Coronavirus Disease 19 (COVID-19) can cause serious lung inflammation and death. COVID-19 is characterized by a high mortality rate. This severity is associated with the overproduction of proinflammatory cytokines called "cytokine storms". One of the cytokines that play a central role is Interleukin-6 (IL-6). High IL-6 levels are associated with mortality. Expectedly, the IL-6 blockade could reduce cytokine storms and thus reduce deaths in severe COVID-19 patients. This systematic review aimed to summarize the comparison between mortality using anti-IL-6 therapy and mortality using standard treatment in severe COVID-19 patients. We systematically searched the PubMed, ScienceDirect, and ProQuest databases until 13 August 2020. After screening, twelve studies matched the inclusion criteria. The mortality of the anti-IL-6 therapy group was lower than the standard treatment group without anti-IL-6 therapy in COVID-19 patients in 10 of the 12 studies obtained. Four of the ten studies statistically found a significant difference in mortality of the anti-IL-6 therapy group and the standard treatment group. Confirmation of anti-IL-6 therapy effectiveness in reducing mortality in severe COVID-19 patients will require randomized controlled trials.
Kata kunci
Jaringan kolaborasi para penulis
24 penulis · 64 tautan kepenulisan bersama · 14 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Universitas Airlangga
- Rumah Sakit Dokter Soetomo
- University of Technology Malaysia
- Universitas Pattimura
- Mulawarman University
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Annette d’Arqom | Universitas Airlangga | 2 |
| Mhd Zamal Nasution | Universitas Airlangga | 2 |
| Sri Purwaningsih | Universitas Airlangga | 1 |
| Yuani Setiawati | Universitas Airlangga | 1 |
| Farhan Nurdiansyah | Universitas Airlangga | 1 |
| Nurmawati Fatimah | Universitas Airlangga | 1 |
| Kusuma Eko Purwantari | Universitas Airlangga | 1 |
| Qonita Bajuber | Universitas Airlangga | 1 |
| Edward Kusuma | Universitas Airlangga | 1 |
| Junaidah Yusof | University of Technology Malaysia | 1 |
| Kinesha Kostya | Universitas Airlangga | 1 |
| Nazwa Febry Savira | Universitas Airlangga | 1 |
| Juen Carla Warella | Universitas Pattimura | 1 |
| Rebekah Juniati Setiabudi | Universitas Airlangga | 1 |
| Khairunnida Rahma | Mulawarman University | 1 |
| Ahmad Veri Erianto | Universitas Airlangga | 1 |
| Tri Pudy Asmarawati | Rumah Sakit Dokter Soetomo | 1 |
| Brian Eka Rachman | Rumah Sakit Dokter Soetomo | 1 |
| Budi Suprapti | Universitas Airlangga | 1 |
| Muhammad Thariq Nadhafi | Afiliasi tidak diketahui | 1 |
| Bambang Wahjuprajitno | Afiliasi tidak diketahui | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.